GUJTERC (GUJARAT TERCE LABORATORIES LTD.) Stock Analysis
Buy, Hold or Sell?
Let's analyze GUJARAT TERCE LABORATORIES LTD. together
I guess you are interested in GUJARAT TERCE LABORATORIES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.
- π Fundamental Analysis (FA) β GUJARAT TERCE LABORATORIES LTD.βs Financial Insights
- π Technical Analysis (TA) β GUJARAT TERCE LABORATORIES LTD.βs Price Targets
I'm going to help you getting a better view of GUJARAT TERCE LABORATORIES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.
Get notifications about GUJARAT TERCE LABORATORIES LTD.
I send you an email if I find something interesting about GUJARAT TERCE LABORATORIES LTD..
1. Quick Overview
1.1. Quick analysis of GUJARAT TERCE LABORATORIES LTD. (30 sec.)
1.2. What can you expect buying and holding a share of GUJARAT TERCE LABORATORIES LTD.? (30 sec.)
How much money do you get?
How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%
What is your share worth?
Current worth
INR8.73
Expected worth in 1 year
INR5.34
How sure are you?
57.1%
+ What do you gain per year?
Total Gains per Share
INR-3.39
Return On Investment
-8.4%
3rd party ad 
SUPPORTERis ad-free.
SUPPORTERis ad-free.2. Detailed Analysis
2.1. Valuation of GUJARAT TERCE LABORATORIES LTD. (5 min.)
Live pricePrice per Share (EOD)
INR40.15
INR8.73
Intrinsic Value Per Share
INR19.57 - INR131.69
Total Value Per Share
INR28.30 - INR140.42
2.2. Growth of GUJARAT TERCE LABORATORIES LTD. (5 min.)
Is GUJARAT TERCE LABORATORIES LTD. growing?
| Current year | Previous year | Grow | Grow % | |
|---|---|---|---|---|
| How rich? | $64.7m | $71m | -$6.2m | -9.7% |
How much money is GUJARAT TERCE LABORATORIES LTD. making?
| Current year | Previous year | Grow | Grow % | |
|---|---|---|---|---|
| Making money | -$9.7m | $2.4m | -$12.2m | -124.9% |
| Net Profit Margin | -1.9% | 0.5% | - | - |
How much money comes from the company's main activities?
2.3. Financial Health of GUJARAT TERCE LABORATORIES LTD. (5 min.)
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.3. Summary and Key Metrics
3.1. What can you expect buying and holding a share of GUJARAT TERCE LABORATORIES LTD.?
Welcome investor! GUJARAT TERCE LABORATORIES LTD.'s management wants to use your money to grow the business. In return you get a share of GUJARAT TERCE LABORATORIES LTD..
First you should know what it really means to hold a share of GUJARAT TERCE LABORATORIES LTD.. And how you can make/lose money.
Speculation
The Price per Share of GUJARAT TERCE LABORATORIES LTD. is INR40.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.
If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:
- The fundamentals: the financial health trends of GUJARAT TERCE LABORATORIES LTD..
- The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
- The book value: what is the market price compared to it's book value.
Investing
If you really want to invest in GUJARAT TERCE LABORATORIES LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:
- You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR8.73. Based on the TTM, the Book Value Change Per Share is INR-0.85 per quarter. Based on the YOY, the Book Value Change Per Share is INR0.33 per quarter.
- You may receive quarterly/yearly dividend in the form of additional shares.
- You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
How much money are you going to get?
| MRQ | TTM | YOY | 3Y | 5Y | 10Y | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INR | % of Price per Share | INR | % of Price per Share | INR | % of Price per Share | INR | % of Price per Share | INR | % of Price per Share | INR | % of Price per Share | |
| Usd Eps | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% |
| Usd Book Value Change Per Share | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% |
| Usd Dividend Per Share | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% |
| Usd Total Gains Per Share | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% | 0.00 | 0.0% |
| Usd Price Per Share | 0.00 | - | 0.00 | - | 0.00 | - | 0.00 | - | 0.00 | - | 0.00 | - |
| Price to Earnings Ratio | -46.36 | - | -46.36 | - | 161.36 | - | 35.87 | - | 25.56 | - | 22.92 | - |
| Price-to-Total Gains Ratio | -72.18 | - | -72.18 | - | 161.42 | - | 27.28 | - | 20.52 | - | 17.17 | - |
| Price to Book Ratio | 7.00 | - | 7.00 | - | 5.53 | - | 4.78 | - | 3.46 | - | 2.62 | - |
| Price-to-Total Gains Ratio | -72.18 | - | -72.18 | - | 161.42 | - | 27.28 | - | 20.52 | - | 17.17 | - |
When do you get the money?
| Usd Investment | |
|---|---|
| Usd Price Per Share | 0 |
| Number of shares | INF |
| Gains per Quarter | Trailing 12 Months | 5 Year |
|---|---|---|
| Usd Dividend Per Share | 0.00 | 0.00 |
| Usd Book Value Change Per Share | 0.00 | 0.00 |
| Usd Total Gains Per Share | 0.00 | 0.00 |
| Gains per Quarter (INF shares) | nan | nan |
| Gains per Year (INF shares) | nan | nan |
| Years | Return on Investment (TTM) | Return on Investment (5Y) | ||||
|---|---|---|---|---|---|---|
| Dividend | Book Value gain | Total gains | Dividend | Book Value gain | Total gains | |
| Broker costs | - | - | -10 | - | - | -10 |
| 1 | NAN | NAN | NAN | NAN | NAN | NAN |
| 2 | NAN | NAN | NAN | NAN | NAN | NAN |
| 3 | NAN | NAN | NAN | NAN | NAN | NAN |
| 4 | NAN | NAN | NAN | NAN | NAN | NAN |
| 5 | NAN | NAN | NAN | NAN | NAN | NAN |
| 6 | NAN | NAN | NAN | NAN | NAN | NAN |
| 7 | NAN | NAN | NAN | NAN | NAN | NAN |
| 8 | NAN | NAN | NAN | NAN | NAN | NAN |
| 9 | NAN | NAN | NAN | NAN | NAN | NAN |
| 10 | NAN | NAN | NAN | NAN | NAN | NAN |
How sure are you?
Based on the past periods, how sure are you to get value out of your investment.
Linear %
| Trailing 12 Months | 3Y | 5 Year | 10 Year | ALLTIME | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | % | % | % | % | ||||||||||||||||
| Earnings Per Share | 0.0 | 1.0 | 0.0 | 0.0% | 1.0 | 2.0 | 0.0 | 33.3% | 2.0 | 3.0 | 0.0 | 40.0% | 4.0 | 3.0 | 0.0 | 57.1% | 4.0 | 3.0 | 0.0 | 57.1% |
| Book Value Change Per Share | 0.0 | 1.0 | 0.0 | 0.0% | 1.0 | 2.0 | 0.0 | 33.3% | 2.0 | 3.0 | 0.0 | 40.0% | 4.0 | 3.0 | 0.0 | 57.1% | 4.0 | 3.0 | 0.0 | 57.1% |
| Dividend per Share | 0.0 | 0.0 | 1.0 | 0.0% | 0.0 | 0.0 | 3.0 | 0.0% | 0.0 | 0.0 | 5.0 | 0.0% | 0.0 | 0.0 | 7.0 | 0.0% | 0.0 | 0.0 | 7.0 | 0.0% |
| Total Gains per Share | 0.0 | 1.0 | 0.0 | 0.0% | 1.0 | 2.0 | 0.0 | 33.3% | 2.0 | 3.0 | 0.0 | 40.0% | 4.0 | 3.0 | 0.0 | 57.1% | 4.0 | 3.0 | 0.0 | 57.1% |
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.3.2. Key Performance Indicators
The key performance indicators of GUJARAT TERCE LABORATORIES LTD. compared to the Most Recent Quarter (MRQ).
| End of day | +/- | Most Recent Quarter | Trailing 12 Months | +/- | Year-Over-Year | +/- | 3Y | +/- | 5 Year | +/- | 10 Year | +/- | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value Change Per Share | - | - | -0.847 | -0.847 | 0% | 0.328 | -358% | -0.924 | +9% | -1.249 | +47% | 1.247 | -168% |
| Book Value Per Share | - | - | 8.730 | 8.730 | 0% | 9.577 | -9% | 9.185 | -5% | 9.876 | -12% | 11.280 | -23% |
| Current Ratio | - | - | 0.951 | 0.951 | 0% | 0.924 | +3% | 0.947 | +0% | 1.008 | -6% | 1.101 | -14% |
| Debt To Asset Ratio | - | - | 0.716 | 0.716 | 0% | 0.695 | +3% | 0.723 | -1% | 0.702 | +2% | 0.636 | +13% |
| Debt To Equity Ratio | - | - | 2.524 | 2.524 | 0% | 2.275 | +11% | 2.652 | -5% | 2.404 | +5% | 1.974 | +28% |
| Dividend Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Enterprise Value | - | - | 290177142.000 | 290177142.000 | 0% | 231230885.000 | +25% | 142795408.333 | +103% | 68678471.600 | +323% | 37225508.714 | +680% |
| Eps | - | - | -1.319 | -1.319 | 0% | 0.328 | -502% | -1.081 | -18% | -1.093 | -17% | -0.644 | -51% |
| Ev To Sales Ratio | - | - | 0.578 | 0.578 | 0% | 0.482 | +20% | 0.287 | +101% | 0.103 | +461% | 0.041 | +1319% |
| Free Cash Flow Per Share | - | - | 4.123 | 4.123 | 0% | 3.404 | +21% | 2.493 | +65% | 0.626 | +558% | -0.146 | +104% |
| Free Cash Flow To Equity Per Share | - | - | 4.123 | 4.123 | 0% | 3.404 | +21% | 2.493 | +65% | 0.626 | +558% | 0.223 | +1751% |
| Gross Profit Margin | - | - | 1.000 | 1.000 | 0% | 1.000 | 0% | 1.000 | 0% | 1.000 | 0% | 1.000 | 0% |
| Intrinsic Value_10Y_max | - | - | 131.694 | - | - | - | - | - | - | - | - | - | - |
| Intrinsic Value_10Y_min | - | - | 19.571 | - | - | - | - | - | - | - | - | - | - |
| Intrinsic Value_1Y_max | - | - | 4.811 | - | - | - | - | - | - | - | - | - | - |
| Intrinsic Value_1Y_min | - | - | 0.973 | - | - | - | - | - | - | - | - | - | - |
| Intrinsic Value_3Y_max | - | - | 20.846 | - | - | - | - | - | - | - | - | - | - |
| Intrinsic Value_3Y_min | - | - | 3.796 | - | - | - | - | - | - | - | - | - | - |
| Intrinsic Value_5Y_max | - | - | 44.586 | - | - | - | - | - | - | - | - | - | - |
| Intrinsic Value_5Y_min | - | - | 7.555 | - | - | - | - | - | - | - | - | - | - |
| Market Cap | 297925045.000 | -52% | 453677142.000 | 453677142.000 | 0% | 392904885.000 | +15% | 323401408.333 | +40% | 243178071.600 | +87% | 190055083.857 | +139% |
| Net Profit Margin | - | - | -0.019 | -0.019 | 0% | 0.005 | -484% | -0.017 | -14% | -0.026 | +32% | -0.015 | -21% |
| Operating Margin | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | 0.003 | -100% |
| Operating Ratio | - | - | 1.313 | 1.313 | 0% | 1.353 | -3% | 1.380 | -5% | 1.402 | -6% | 1.392 | -6% |
| Pb Ratio | 4.599 | -52% | 7.004 | 7.004 | 0% | 5.529 | +27% | 4.778 | +47% | 3.456 | +103% | 2.618 | +167% |
| Pe Ratio | -30.441 | +34% | -46.355 | -46.355 | 0% | 161.357 | -129% | 35.869 | -229% | 25.560 | -281% | 22.917 | -302% |
| Price Per Share | 40.150 | -52% | 61.140 | 61.140 | 0% | 52.950 | +15% | 43.583 | +40% | 32.772 | +87% | 25.613 | +139% |
| Price To Free Cash Flow Ratio | 9.739 | -52% | 14.830 | 14.830 | 0% | 15.554 | -5% | -103.079 | +795% | -64.911 | +538% | -47.644 | +421% |
| Price To Total Gains Ratio | -47.403 | +34% | -72.184 | -72.184 | 0% | 161.424 | -145% | 27.281 | -365% | 20.518 | -452% | 17.175 | -520% |
| Quick Ratio | - | - | 0.481 | 0.481 | 0% | 0.466 | +3% | 0.476 | +1% | 0.480 | +0% | 0.551 | -13% |
| Return On Assets | - | - | -0.043 | -0.043 | 0% | 0.010 | -510% | -0.030 | -29% | -0.035 | -19% | -0.020 | -53% |
| Return On Equity | - | - | -0.151 | -0.151 | 0% | 0.034 | -541% | -0.120 | -20% | -0.117 | -22% | -0.075 | -51% |
| Total Gains Per Share | - | - | -0.847 | -0.847 | 0% | 0.328 | -358% | -0.924 | +9% | -1.249 | +47% | 1.247 | -168% |
| Usd Book Value | - | - | 64776000.000 | 64776000.000 | 0% | 71061000.000 | -9% | 68154666.667 | -5% | 73285400.000 | -12% | 83697775.429 | -23% |
| Usd Book Value Change Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Book Value Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Dividend Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Enterprise Value | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Eps | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Free Cash Flow | - | - | 30591000.000 | 30591000.000 | 0% | 25260000.000 | +21% | 18495666.667 | +65% | 4646800.000 | +558% | -1082069.143 | +104% |
| Usd Free Cash Flow Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Free Cash Flow To Equity Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Market Cap | 297925045.000 | +100% | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Price Per Share | 40.150 | +100% | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| Usd Profit | - | - | -9787000.000 | -9787000.000 | 0% | 2435000.000 | -502% | -8022666.667 | -18% | -8109400.000 | -17% | -4779952.000 | -51% |
| Usd Revenue | - | - | 501952000.000 | 501952000.000 | 0% | 479747000.000 | +5% | 483174666.667 | +4% | 420528000.000 | +19% | 398340557.857 | +26% |
| Usd Total Gains Per Share | - | - | - | - | 0% | - | 0% | - | 0% | - | 0% | - | 0% |
| EOD | +6 -2 | MRQ | TTM | +0 -0 | YOY | +12 -14 | 3Y | +15 -11 | 5Y | +13 -13 | 10Y | +9 -18 |
3.3 Fundamental Score
Let's check the fundamental score of GUJARAT TERCE LABORATORIES LTD. based on Penke's default stock scanner.
Penke's Stock Scanner
| Indicator | Condition | Value | ||
|---|---|---|---|---|
| Price to Earnings Ratio (EOD) | Between | 0-15 | -30.441 | |
| Price to Book Ratio (EOD) | Between | 0-1 | 4.599 | |
| Net Profit Margin (MRQ) | Greater than | 0 | -0.019 | |
| Operating Margin (MRQ) | Greater than | 0 | 0.000 | |
| Quick Ratio (MRQ) | Greater than | 1 | 0.481 | |
| Current Ratio (MRQ) | Greater than | 1 | 0.951 | |
| Debt to Asset Ratio (MRQ) | Less than | 1 | 0.716 | |
| Debt to Equity Ratio (MRQ) | Less than | 1 | 2.524 | |
| Return on Equity (MRQ) | Greater than | 0.15 | -0.151 | |
| Return on Assets (MRQ) | Greater than | 0.05 | -0.043 | |
| Total | 1/10 (10.0%) | |||
3.4 Technical Score
Let's check the technical score of GUJARAT TERCE LABORATORIES LTD. based on Penke's default Symbol scanner.
Penke's Symbol Scanner
| Indicator | Condition | Value | ||
|---|---|---|---|---|
| Open | Greater than | Close | 41.500 | |
| Total | 1/1 (100.0%) | |||
4. In-depth Analysis
4.1 About GUJARAT TERCE LABORATORIES LTD.
- https://www.gujaratterce.in
- 286
- D/ 801 - 802 & 1202, The First, Ahmedabad, India, 380015
Google Maps Bing Maps
Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company's products include branded generic pharmaceutical covering various therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides its products in various forms, including tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, and Aziter brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.
Fundamental data was last updated by Penke on 2025-09-09 06:07:05.
4.2 In-depth Summary
4.2.1. Financial Health Summary
Profitability Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| The company is making a loss. | ||
| Using its assets, the company is very inefficient in making profit. | ||
| Using its investors money, the company is very inefficient in making profit. |
Operating Efficiency Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| The company is inefficient in keeping operating costs low. |
Liquidity Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| The company is just not able to pay all its short-term debts. | ||
| The company is just not able to pay all its short-term debts with the most liquid assets. |
Solvency Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| The company is able to pay all its debts by selling its assets. | ||
| The company is unable to pay all its debts with equity. |
4.2.2. Valuation Summary
Valuation Details
| Compared to previous year | Compared to industry | |
|---|---|---|
| Based on the equity, the company is overpriced. | ||
| Based on the earnings, the company is expensive. | ||
| Based on how much money comes from the company's main activities, the company is cheap. |
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.4.3 Financial Health
4.3.1. Profitability
4.3.1 Profitability
4.3.1.1. Net Profit Margin
Measures how much net profitΒ GUJARAT TERCE LABORATORIES LTD. earns for each ₹1 of revenue.
- Above 10% is considered healthy but always compareΒ GUJARAT TERCE LABORATORIES LTD. to theΒ Drug Manufacturers - Specialty & Generic industry mean.
- A Net Profit Margin of -1.9%Β means thatΒ ₹-0.02 for each ₹1Β in revenue is generated as profit.
Let's take a look of the Net Profit Margin trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 0.5%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -2.6%. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is -1.5%. Compared to the 5Y term, the 10Y term is trending down. -2
4.3.1.2. Return on Assets
Shows howΒ efficientΒ GUJARAT TERCE LABORATORIES LTD. is using its assets to generate profit.
- Above 5% is considered healthyΒ but always compareΒ GUJARAT TERCE LABORATORIES LTD. to theΒ Drug Manufacturers - Specialty & Generic industry mean.
- -4.3% Return on Assets means thatΒ GUJARAT TERCE LABORATORIES LTD. generatedΒ ₹-0.04 profit for each $1 in assets.
Let's take a look of the Return on Assets trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 1.0%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -3.5%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is -2.0%. Compared to the 5Y term, the 10Y term is trending down. -2
4.3.1.3. Return on Equity
Shows how efficient GUJARAT TERCE LABORATORIES LTD. is using its investors money to generate profit.
- Above 15%-20% is considered healthy but always compareΒ GUJARAT TERCE LABORATORIES LTD. to theΒ Drug Manufacturers - Specialty & Generic industry mean.
- -15.1% Return on Equity means GUJARAT TERCE LABORATORIES LTD. generated ₹-0.15Β for eachΒ ₹1 the owners (shareholders) invested.
Let's take a look of the Return on Equity trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 3.4%. Compared to the TTM, the mid term is trending down. -2
- The 5Y is -11.7%. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is -7.5%. Compared to the 5Y term, the 10Y term is trending down. -2
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.4.3.2. Operating Efficiency of GUJARAT TERCE LABORATORIES LTD..
4.3.2. Operating Efficiency
4.3.2.1. Operating Margin
MeasuresΒ how efficient GUJARAT TERCE LABORATORIES LTD. is operatingΒ .
- Measures how much profit GUJARAT TERCE LABORATORIES LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
- Above 15% is considered healthy but always compareΒ GUJARAT TERCE LABORATORIES LTD. to theΒ Drug Manufacturers - Specialty & Generic industry mean.
- An Operating Margin of 0.0%Β means the company generated ₹0.00 Β for each ₹1 in revenue (before taxes).
Let's take a look of the Operating Margin trends of GUJARAT TERCE LABORATORIES LTD.:
- The MRQ is 0.0%. The data is not here.
Trends
4.3.2.2. Operating Ratio
Measures how efficient GUJARAT TERCE LABORATORIES LTD. is keepingΒ operating costsΒ low.
- Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
- An Operation Ratio of 1.31 means that the operating costs are ₹1.31 for each ₹1 in net sales.
Let's take a look of the Operating Ratio trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 1.353. Compared to the TTM, the mid term is trending down. +2
- The 5Y is 1.402. Compared to the TTM, the 5Y term is trending down. +2
- The 10Y is 1.392. Compared to the 5Y term, the 10Y term is trending up. -2
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.4.4.3. Liquidity of GUJARAT TERCE LABORATORIES LTD..
4.4.3. Liquidity
4.4.3.1. Current Ratio
Measures if GUJARAT TERCE LABORATORIES LTD. is able to pay off Short-term Debt.
- Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
- A Current Ratio of 0.95Β means the company has ₹0.95 in assets for each ₹1 in short-term debts.
Let's take a look of the Current Ratio trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 0.924. Compared to the TTM, the mid term is trending up. +2
- The 5Y is 1.008. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 1.101. Compared to the 5Y term, the 10Y term is trending down. -2
4.4.3.2. Quick Ratio
Measures if GUJARAT TERCE LABORATORIES LTD. is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.
- Above 1 is considered healthy butΒ always compareΒ GUJARAT TERCE LABORATORIES LTD. to theΒ Drug Manufacturers - Specialty & Generic industry mean.
- A Quick Ratio of 0.48Β means the company can pay off ₹0.48 for each ₹1 in debt (using most liquid assets).
Let's take a look of the Quick Ratio trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 0.466. Compared to the TTM, the mid term is trending up. +2
- The 5Y is 0.480. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is 0.551. Compared to the 5Y term, the 10Y term is trending down. -2
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.4.5.4. Solvency of GUJARAT TERCE LABORATORIES LTD..
4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio
Measures how much %Β of GUJARAT TERCE LABORATORIES LTD.Β assets are financed with debt.
- Below 1 (100%) is considered healthy but always compareΒ GUJARAT TERCE LABORATORIES LTD. to Drug Manufacturers - Specialty & Generic industry mean.
- A Debt to Asset Ratio of 0.72Β means that GUJARAT TERCE LABORATORIES LTD. assets areΒ financed with 71.6% credit (debt) and the remaining percentage (100% - 71.6%)Β is financed by its owners/shareholders.Β
Let's take a look of the Debt to Asset Ratio trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 0.695. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 0.702. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is 0.636. Compared to the 5Y term, the 10Y term is trending up. -2
4.5.4.2. Debt to Equity Ratio
Measures ifΒ GUJARAT TERCE LABORATORIES LTD. is able toΒ pay off its debts by usingΒ shareholders equity.
- Below 2 is considered healthy butΒ always compareΒ GUJARAT TERCE LABORATORIES LTD. to theΒ Drug Manufacturers - Specialty & Generic industry mean.
- A Debt to Equity ratio of 252.4% means that company has ₹2.52 debt for each ₹1 in shareholders equity.
Let's take a look of the Debt to Equity Ratio trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 2.275. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 2.404. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is 1.974. Compared to the 5Y term, the 10Y term is trending up. -2
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.4.6. Market Valuation
4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio
MeasuresΒ how much money you payΒ for each share forΒ every ₹1 in earnings GUJARAT TERCE LABORATORIES LTD. generates.
- Above 15 is considered overpriced butΒ always compareΒ GUJARAT TERCE LABORATORIES LTD. to theΒ Drug Manufacturers - Specialty & Generic industry mean.
- A PE ratio of -46.36 means the investor is paying ₹-46.36Β for every ₹1 in earnings.
Let's take a look of the Price to Earnings Ratio trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 161.357. Compared to the TTM, the mid term is trending down. -2
- The 5Y is 25.560. Compared to the TTM, the 5Y term is trending down. -2
- The 10Y is 22.917. Compared to the 5Y term, the 10Y term is trending up. -2
4.6.2.2. Price To Free Cash Flow Ratio
Let's take a look of the Price To Free Cash Flow Ratio trends of GUJARAT TERCE LABORATORIES LTD.:
- The EOD is 9.739. Based on how much money comes from the company's main activities, the company is cheap. +2
- The MRQ is 14.830. Based on how much money comes from the company's main activities, the company is cheap. +2
- The TTM is 14.830. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
- The YOY is 15.554. Compared to the TTM, the mid term is trending down. +2
- The 5Y is -64.911. Compared to the TTM, the 5Y term is trending up. +2
- The 10Y is -47.644. Compared to the 5Y term, the 10Y term is trending down. +2
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio
Measures if the stock price ofΒ GUJARAT TERCE LABORATORIES LTD. is to cheap or to expensiveΒ compared to its book value.
- At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
- A PB ratio of 7.00 means the investor is paying ₹7.00Β for each ₹1 in book value.
Let's take a look of the Price to Book Ratio trends of GUJARAT TERCE LABORATORIES LTD.:
Trends
- The YOY is 5.529. Compared to the TTM, the mid term is trending up. -2
- The 5Y is 3.456. Compared to the TTM, the 5Y term is trending up. -2
- The 10Y is 2.618. Compared to the 5Y term, the 10Y term is trending up. -2
4.6.2. Total Gains per Share
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.6. Financial Statements
6.1. Latest Balance Sheet
Balance Sheet of 2025-03-31. Currency in INR. All numbers in thousands.
Summary
| As reported | |
|---|---|
| Total Liabilities | 163,500 |
| Total Stockholder Equity | + 64,776 |
| Total Assets | = 228,276 |
Assets
Total Current Assets
Long-term Assets
| Property Plant Equipment | 36,540 |
| Long-term Assets Other | 44,788 |
| Long-term Assets (as reported) | 108,027 |
|---|---|
| Long-term Assets (calculated) | 81,328 |
| +/- | 26,699 |
Liabilities & Shareholders' Equity
Total Current Liabilities
Long-term Liabilities
| Long term Debt | 2,977 |
| Long-term Liabilities Other | -1 |
| Long-term Liabilities (as reported) | 37,069 |
|---|---|
| Long-term Liabilities (calculated) | 2,976 |
| +/- | 34,093 |
Total Stockholder Equity
| Total Stockholder Equity (as reported) | 64,776 |
|---|---|
| Total Stockholder Equity (calculated) | 0 |
| +/- | 64,776 |
Other
| Capital Stock | 74,203 |
| Common Stock Shares Outstanding | 7,420 |
| Net Debt | 1,625 |
| Net Invested Capital | 74,195 |
| Net Working Capital | -6,182 |
| Property Plant and Equipment Gross | 87,509 |
6.2. Balance Sheets Structured
Currency in INR. All numbers in thousands.
| Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 | 2018-03-31 | 2017-03-31 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| > Total Assets |
| 228,276 | 232,735 | 285,271 | 273,905 | 218,738 | 223,394 | 193,373 | 0 | 0 | |||||||||
| > Total Current Assets |
| 120,249 | 112,215 | 160,479 | 154,750 | 120,231 | 119,121 | 92,197 | 95,172 | 126,161 | |||||||||
| Cash And Cash Equivalents |
| 7,794 | 900 | 20,299 | 15,092 | 12,864 | 417 | 1,827 | 0 | 0 | |||||||||
| Short-term Investments |
| 10,114 | 0 | 0 | 15,000 | 0 | 0 | 0 | 0 | 0 | |||||||||
| Net Receivables |
| 50,686 | 56,631 | 79,860 | 54,747 | 51,747 | 72,220 | 45,535 | 47,418 | 79,190 | |||||||||
| Inventory |
| 37,073 | 39,850 | 44,298 | 64,311 | 37,393 | 34,332 | 37,782 | 37,901 | 39,739 | |||||||||
| Other Current Assets |
| 12,661 | 3 | -1 | -2 | 2 | 9,549 | 4,626 | 1,420 | 545 | |||||||||
| > Long-term Assets |
| 108,027 | 120,520 | 124,793 | 119,155 | 98,507 | 104,272 | 101,176 | 0 | 0 | |||||||||
| Property Plant Equipment |
| 36,540 | 36,915 | 39,879 | 42,928 | 24,544 | 23,002 | 20,604 | 18,772 | 61,684 | |||||||||
| Long-term Assets Other |
| 44,788 | 72 | 71 | 72 | 73 | -424 | -424 | 0 | 0 | |||||||||
| > Total Liabilities |
| 163,500 | 161,674 | 216,644 | 188,562 | 142,118 | 112,284 | 85,025 | 0 | 0 | |||||||||
| > Total Current Liabilities |
| 126,431 | 121,416 | 166,080 | 132,136 | 117,117 | 92,849 | 66,692 | 71,204 | 60,773 | |||||||||
| Short Long Term Debt |
| 6,442 | 29,392 | 58,110 | 43,717 | 43,124 | 24,407 | 5,536 | 0 | 0 | |||||||||
| Accounts payable |
| 36,142 | 47,130 | 58,509 | 40,250 | 28,486 | 31,890 | 28,107 | 33,234 | 15,824 | |||||||||
| Other Current Liabilities |
| 2,209 | 3,476 | 2,717 | 2,697 | 2,167 | 4,070 | 2,944 | 2,522 | 3,224 | |||||||||
| > Long-term Liabilities |
| 37,069 | 40,258 | 50,564 | 56,426 | 25,001 | 19,435 | 18,333 | 0 | 0 | |||||||||
| Long-term Liabilities Other |
| -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||||
| > Total Stockholder Equity |
| 64,776 | 71,061 | 68,627 | 85,343 | 76,620 | 111,110 | 108,348 | 0 | 0 | |||||||||
| Retained Earnings |
| -32,103 | -22,318 | -24,752 | -8,036 | -16,759 | 21,907 | 19,145 | 14,381 | 10,926 | |||||||||
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Capital Surplus | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||||||
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
6.3. Balance Sheets
Currency in INR. All numbers in thousands.
6.4. Cash Flows
Currency in INR. All numbers in thousands.
6.5. Income Statements
Currency in INR. All numbers in thousands.
6.6. Latest Income Statement
Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.
| Gross Profit (+$) | ||
|---|---|---|
| totalRevenue | 501,952 | |
| Cost of Revenue | -192,103 | |
| Gross Profit | 309,849 | 309,849 |
| Operating Income (+$) | ||
| Gross Profit | 309,849 | |
| Operating Expense | -466,784 | |
| Operating Income | 35,168 | -156,935 |
| Operating Expense (+$) | ||
| Research Development | 0 | |
| Selling General Administrative | 57,935 | |
| Selling And Marketing Expenses | 0 | |
| Operating Expense | 466,784 | 57,935 |
| Net Interest Income (+$) | ||
| Interest Income | 2,560 | |
| Interest Expense | -3,616 | |
| Other Finance Cost | -537 | |
| Net Interest Income | -1,593 | |
| Pretax Income (+$) | ||
| Operating Income | 35,168 | |
| Net Interest Income | -1,593 | |
| Other Non-Operating Income Expenses | 0 | |
| Income Before Tax (EBT) | 33,904 | 35,168 EBIT - interestExpense = -3,616 -9,787 -6,171 |
| Interest Expense | 3,616 | |
| Earnings Before Interest and Taxes (EBIT) | 0 | 37,520 |
| Earnings Before Interest and Taxes (EBITDA) | 0 | |
| After tax Income (+$) | ||
| Income Before Tax | 33,904 | |
| Tax Provision | -43,691 | |
| Net Income From Continuing Ops | -9,787 | -9,787 |
| Net Income | -9,787 | |
| Net Income Applicable To Common Shares | 0 | |
| Non-recurring Events | ||
| Discontinued Operations | 0 | |
| Extraordinary Items | 0 | |
| Effect of Accounting Charges | 0 | |
| Other Items | 0 | |
| Non Recurring | 0 | |
| Other Operating Expenses | 0 | |
| Total Other Income/Expenses Net | 0 | 1,593 |
Technical Analysis of GUJARAT TERCE LABORATORIES LTD.
The psychology behind the price
Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.
General trend
First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of GUJARAT TERCE LABORATORIES LTD.. The general trend of GUJARAT TERCE LABORATORIES LTD. is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine GUJARAT TERCE LABORATORIES LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.
Indicator phases
Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:
| Indicator State | Bullish trend | Bearish trend | |
|---|---|---|---|
| Overbought to neutral | Bullish pullback | = | Bearish reversal |
| Upper to lower neutral | Bullish correction | = | Bearish continuation |
| Nuetral to oversold | Oversold | = | Oversold |
| Oversold to neutral | Bullish reversal | = | Bearish correction |
| Lower to upper neutral | Bullish continuation | = | Bearish pullback |
| Nuetral to overbought | Overbought | = | Overbought |
1. GUJARAT TERCE LABORATORIES LTD. Price Targets
1.1 Support & Resistance
Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.
SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.
Score
Let's take a look at the Support & Resistance of GUJARAT TERCE LABORATORIES LTD..
The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).
- Between support/resistance: The price is trading between support and resistance lines.
The bullish price targets are: 44.52 < 45.00 < 45.00.
The bearish price targets are: 37.30 > 37.20 > 36.58.
Know someone who trades $GUJTERC? Share this with them.π
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.2. Trend Indicators
2.1 Moving Averages
Shows theΒ moving averageΒ of the selected period.
- Moving averages are laggingΒ trend indicators.
- There are many types of moving averages.
- Moving averages are also used within other indicators.
Score
Let's take a look at the Moving Averages of GUJARAT TERCE LABORATORIES LTD.. The current mas is .
Directionalities and relatives.
| Moving Average | Amount of candles | Trend | Price +/- | vs. MA 50 | vs. MA 100 | vs. MA 200 |
|---|
Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I
2.2 Moving Average Convergence/Divergence (MACD)
Shows theΒ momentumΒ of theΒ selected period based on two moving averages.
- MACD is aΒ lagging momentumΒ indicator.
- Uses two moving averages.
- Can show buy or sell signals based on momentum.
- Can show overbought. and oversold. levels.
Score
Let's take a look at the Moving Average Convergence/Divergence (MACD) of GUJARAT TERCE LABORATORIES LTD..
2.3 Directional Movement Index (DMI)
The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.
Score
Let's take a look at the Directional Movement Index (DMI) of GUJARAT TERCE LABORATORIES LTD.. The current adx is .
2.4 Parabolic SAR
Shows the current trend and potential entry and exit signals.
- Parabolic SAR (stop and reverse) is a lagging trend indicator.
- ShowsΒ the current trend.
- ShowsΒ potential entry signals.
- ShowsΒ Β potential exit signals.
- Can be used to placeΒ trailing stoplosses..
Score
Let's take a look at the Parabolic SAR of GUJARAT TERCE LABORATORIES LTD..
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.3. Momentum Indicators
3.1 Relative Strength Index (RSI)
Measures the speed and change of price movements.
- Leading momentumΒ indicator, meaning the signals are instant.
- RangesΒ between 0 and 100.
- Above 70 is considered overbought.
- Below 30 is considered oversold.
- Above or below 50 can also be used to determine price trend or support and resistance.
- RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
- Can be used in many different ways
Score
Let's take a look at the Relative Strength Index (RSI) of GUJARAT TERCE LABORATORIES LTD..
3.2 Stochastic Oscillator
ComparesΒ a certain price to multiple prices ranging over time.
- LeadingΒ momentumΒ indicator, meaning the signals are instant.
- Used to determine overbought and oversold areas much like the RSI.
- RangesΒ between 0 and 100.
- Above 80 is considered overbought.
- Below 20 is considered oversold.
- Consists of two lines named K and D.
- K compares the highest high and lowest low on the selected price range.
- The D line is a moving average of the K line.
- Can be used to spot divergences
Score
Let's take a look at the Stochastic Oscillator of GUJARAT TERCE LABORATORIES LTD..
3.3 Commodity Channel Index (CCI)
Measures the difference between the current price and the historical average price.
- Lagging or leading Momentum indicator
- When the CCI is above zero, the price is above the historical average
- When the CCI is below zero,Β the price is below the historical average
- Used for spotting trends
- If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
- If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend
Score
Let's take a look at the Commodity Channel Index (CCI) of GUJARAT TERCE LABORATORIES LTD..
3.4 Chande Momentum Oscillator (CMO)
Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.
- Lagging momentum indicator
- Ranges between +100 and -100
- Considered overbought above +50
- Considered oversold below -50
- It's possible to add a moving average that acts as a signal line
Score
Let's take a look at the Chande Momentum Oscillator (CMO) of GUJARAT TERCE LABORATORIES LTD..
3.5 Williams %R
Β Shows the current price relative to the highest high over the last 14 days.
- Lagging momentum indicator
- Ranging between 0 andΒ -100
- Above -20 is considered overbought
- Below -80 is considered oversold
- Is prone to give false signals
Score
Let's take a look at the Williams %R of GUJARAT TERCE LABORATORIES LTD..
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.4. Volatility Indicators
4.1 Bollinger Bands
Shows if the price is to high or to low relative to an average.
- Lagging volatility indicator
- Uses 3 bands: one upper, one lower and one in the middle
- Works best when the middle band reflects an intermediate trend (MA20).
- When the price is moving closer to the upper band, the market might be overbought
- When the price is moving closer to the lower band, the market might be oversoldΒ
Score
Let's take a look at the Bollinger Bands of GUJARAT TERCE LABORATORIES LTD..
4.2 Average True Range (ATR)
Measures market volatility
- Leading volatility indicator
- Can be used to determine stop-loss positions
- Calculated by:
- Current high minus the current low
- Current high minus the previous close
- Current low minus the previous close
- The larger the range of the candles, the greater the ATR value
Score
Let's take a look at the Average True Range (ATR) of GUJARAT TERCE LABORATORIES LTD..
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.5. Volume Indicators
5.1 On-Balance Volume (OBV)
Β Measures market volatility
- Leading momentum indicator
- Calculation:
- If the closing price is above the previous closing price: OBV = previous OBV + current volume
- If the closing price is below the previous closing price: OBV = previous OBV - current volume
- If the closing price is the same as the previous closing price than the OBV is the same.
- Can be used to confirm price trends
- Can be used with divergences
Score
Let's take a look at the On-Balance Volume (OBV) of GUJARAT TERCE LABORATORIES LTD..
5.2 Money Flow Index (MFI)
Measures the flow of money in and out of a security
- Lagging momentum indicator
- Looks like RSI but uses volume as an extra metric (RSI only considers price)
- Above 80 is considered overbought
- Below 20 is considered oversold
- Can be used with divergences
Score
Let's take a look at the Money Flow Index (MFI) of GUJARAT TERCE LABORATORIES LTD..
3rd party ad SUPPORTERis ad-free.
SUPPORTERis ad-free.6. Summary
6.1. Notifications
| Type | Notification | Date |
|---|---|---|
 Currently no notifications for GUJARAT TERCE LABORATORIES LTD.. |
6.2. Trading Signals
Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.
| Date | Indicator | Signal | ||
|---|---|---|---|---|
| 2025-04-28 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2025-04-29 | BB | LONG ENTRY | SHORT CLOSE | Price closed below the lower band. |
| 2025-04-30 | MACD | SHORT ENTRY | LONG CLOSE | The MACD line crosses below the signal line. |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2025-05-05 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-05-06 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| 2025-05-07 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-05-08 | MACD | LONG ENTRY | SHORT CLOSE | The MACD line crosses above the signal line. |
| 2025-05-09 | MACD | SHORT ENTRY | LONG CLOSE | The MACD line crosses below the signal line. |
| SAR | SHORT ENTRY | LONG CLOSE | The price broke the SAR to the downside | |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| 2025-05-12 | MACD | LONG ENTRY | SHORT CLOSE | The MACD line crosses above the signal line. |
| STOCH | SHORT EXIT | The %K line crosses above the %D line. | ||
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2025-05-13 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2025-05-14 | CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside |
| 2025-05-15 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2025-05-21 | CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside |
| 2025-05-22 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2025-05-23 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2025-05-26 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2025-05-27 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2025-05-28 | MACD | SHORT ENTRY | LONG CLOSE | The MACD line crosses below the signal line. |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| BB | LONG ENTRY | SHORT CLOSE | Price closed below the lower band. | |
| 2025-05-30 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-06-03 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| 2025-06-04 | MACD | LONG ENTRY | SHORT CLOSE | The MACD line crosses above the signal line. |
| STOCH | SHORT EXIT | The %K line crosses above the %D line. | ||
| 2025-06-05 | CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside |
| 2025-06-06 | CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside |
| 2025-06-09 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2025-06-10 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2025-06-11 | SAR | LONG ENTRY | SHORT CLOSE | The price broke the SAR to the upside. |
| 2025-06-12 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2025-06-13 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CCI | LONG ENTRY | SHORT CLOSE | 100 crossover to upside | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| WILLR | LONG ENTRY | SHORT CLOSE | -20 crossover to upside | |
| 2025-06-16 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2025-06-17 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-06-19 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2025-06-20 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2025-06-23 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside | |
| 2025-06-24 | CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside |
| 2025-06-25 | CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside |
| 2025-06-26 | MACD | SHORT ENTRY | LONG CLOSE | The MACD line crosses below the signal line. |
| SAR | SHORT ENTRY | LONG CLOSE | The price broke the SAR to the downside | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| BB | LONG ENTRY | SHORT CLOSE | Price closed below the lower band. | |
| MFI | SHORT ENTRY | LONG CLOSE | 20 crossover to downside | |
| 2025-06-27 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| 2025-07-01 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| BB | LONG ENTRY | SHORT CLOSE | Price closed below the lower band. | |
| 2025-07-03 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-07-04 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2025-07-07 | WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside |
| 2025-07-11 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-07-16 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| MFI | LONG ENTRY | SHORT CLOSE | 20 crossover to upside | |
| 2025-07-17 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-07-18 | MACD | LONG ENTRY | SHORT CLOSE | The MACD line crosses above the signal line. |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| 2025-07-21 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| SAR | LONG ENTRY | SHORT CLOSE | The price broke the SAR to the upside. | |
| 2025-07-22 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2025-07-23 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-07-24 | SAR | SHORT ENTRY | LONG CLOSE | The price broke the SAR to the downside |
| 2025-07-25 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| SAR | LONG ENTRY | SHORT CLOSE | The price broke the SAR to the upside. | |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| 2025-07-28 | SAR | SHORT ENTRY | LONG CLOSE | The price broke the SAR to the downside |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2025-07-29 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| CMO | LONG ENTRY | SHORT CLOSE | Zero line crossover to upside | |
| 2025-07-31 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2025-08-01 | CMO | SHORT ENTRY | LONG CLOSE | Zero line crossover to downside |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2025-08-06 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-08-07 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| BB | LONG ENTRY | SHORT CLOSE | Price closed below the lower band. | |
| 2025-08-08 | MACD | SHORT ENTRY | LONG CLOSE | The MACD line crosses below the signal line. |
| 2025-08-11 | SAR | LONG ENTRY | SHORT CLOSE | The price broke the SAR to the upside. |
| STOCH | SHORT EXIT | The %K line crosses above the %D line. | ||
| 2025-08-12 | SAR | SHORT ENTRY | LONG CLOSE | The price broke the SAR to the downside |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| BB | LONG ENTRY | SHORT CLOSE | Price closed below the lower band. | |
| ATR | SHORT ENTRY | LONG CLOSE | Price closed below (close - ATR). | |
| 2025-08-18 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-08-19 | RSI | LONG ENTRY | SHORT CLOSE | 30 crossover to upside |
| 2025-08-21 | STOCH | LONG EXIT | The %K line crosses below the %D line. | |
| 2025-08-22 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-08-25 | MACD | LONG ENTRY | SHORT CLOSE | The MACD line crosses above the signal line. |
| 2025-08-26 | MACD | SHORT ENTRY | LONG CLOSE | The MACD line crosses below the signal line. |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| WILLR | SHORT ENTRY | LONG CLOSE | -80 crossover to downside | |
| 2025-09-01 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-09-02 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| 2025-09-03 | DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. |
| RSI | LONG ENTRY | SHORT CLOSE | 30 crossover to upside | |
| 2025-09-05 | DMI | SHORT ENTRY | LONG CLOSE | The +DI crossed the -DI to the downside. The trend is reversing to a down trend. |
| CCI | SHORT ENTRY | LONG CLOSE | -100 crossover to downside | |
| 2025-09-08 | MACD | LONG ENTRY | SHORT CLOSE | The MACD line crosses above the signal line. |
| DMI | LONG ENTRY | SHORT CLOSE | The +DI crossed the -DI to the upside. The trend is reversing to an up trend. | |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| 2025-09-10 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
| 2025-09-11 | SAR | LONG ENTRY | SHORT CLOSE | The price broke the SAR to the upside. |
| STOCH | LONG EXIT | The %K line crosses below the %D line. | ||
| 2025-09-12 | STOCH | SHORT EXIT | The %K line crosses above the %D line. | |
6.3. Candlestick Patterns
| Date | Candlestick Pattern |
|---|
6.4. Technical Score
Let's check the technical score of GUJARAT TERCE LABORATORIES LTD. based on Penke's default Symbol scanner.
Penke's Symbol Scanner
| Indicator | Condition | Value | ||
|---|---|---|---|---|
| Open | Greater than | Close | 41.500 | |
| Total | 1/1 (100.0%) | |||
Good job! You gained 25 XP and 0 0 10 . What's next:
- Share my analysis of GUJARAT TERCE LABORATORIES LTD. with someone you think should read this too:
- Are you bullish or bearish on GUJARAT TERCE LABORATORIES LTD.? Let me know what you think in the comments.
- Do you want an email if I find something interesting about GUJARAT TERCE LABORATORIES LTD.? Add an email alert using the form below.
- Join the community if you want to keep your earnings and track your progress: Join the community
- Is this analysis useful to you? Support me via
. I'll analyze the stock market faster for you!
Get notifications about GUJARAT TERCE LABORATORIES LTD.
I send you an email if I find something interesting about GUJARAT TERCE LABORATORIES LTD..
Comments
How you think about this?